Do you want to read an article? Please log in or register.
Safety and immunogenicity of non-typeable Haemophilus influenzae-Moraxella catarrhalis vaccine
COPD
RECOMMENDED
Related content
COMMENTED
Further Publications
Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial
★ 3
Recommended and commented by
Dr Martin Frey, Faculty Member
Lancet Respir Med
Toback S, Galiza E, Cosgrove C, Galloway J, Goodman AL, Swift PA, Rajaram S, Graves-Jones A, Edelman J, Burns F, Minassian AM, Cho I, Kumar L, Plested JS, Rivers EJ, Robertson A, Dubovsky F, Glenn G, Heath PT, 2019nCoV-302 Study Group.
doi: 10.1016/S2213-2600(21)00409-4
Pneumonia
Effectiveness of pneumococcal Haemophilus influenzae protein D conjugate vaccine against pneumonia in children: A cluster-randomised trial
Vaccine.
Kilpi TM, Jokinen J, Puumalainen T, Nieminen H, Ruokokoski E, Rinta-Kokko H, Traskine M, Lommel P, Moreira M, Ruiz-Guinazu J, Borys D, Schuerman L, Palmu AA
doi: 10.1016/j.vaccine.
RECOMMENDED
Respiratory Tract Infection
Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against all respiratory tract infections in children under two years of age
Vaccine.
Karppinen S, Toivonen L, Schuez-Havupalo L, Teros-Jaakkola T, Waris M, Auranen K, Palmu AA, Peltola V
doi: 10.1016/j.vaccine.2019.04.026.
Respiratory Tract Infection
Serum antibody response to Moraxella catarrhalis proteins in stringently defined otitis prone children
Vaccine
Ren D, Almudevar AL, Murphy TF, Lafontaine ER, Campagnari AA, Luke-Marshall N, Pichichero ME
doi: 10.1016/
COPD
Diesel exhaust alters the response of cultured primary bronchial epithelial cells from patients with chronic obstructive pulmonary disease (COPD) to non-typeable Haemophilus influenzae.
Respir Res.
Zarcone MC, van Schadewijk A, Duistermaat E, Hiemstra PS, Kooter IM
doi: 10.1186/s12931-017-0510-4.
COPD
Relationships between Mucosal Antibodies, Non-Typeable Haemophilus influenzae (NTHi) Infection and Airway Inflammation in COPD.
PLoS One
Staples KJ, Taylor S, Thomas S, Leung S, Cox K, Pascal TG, Ostridge K, Welch L, Tuck AC, Clarke SC, Gorringe A, Wilkinson TM
doi: 10.1371/journal.pone.0167250
RECOMMENDED
Further Publications
Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Lancet Respir Med
Day TA, Penn-Nicholson A, Luabeya AKK, Fiore-Gartland A, Du Plessis N, Loxton AG, Vergara J, Rolf TA, Reid TD, Toefy A, Shenje J, Geldenhuys H, Tameris M, Mabwe S, Bilek N, Bekker LG, Diacon A, Walzl G, Ashman J, Frevol A, Sagawa ZK, Lindestam Arlehamn C, Sette A, Reed SG, Coler RN, Scriba TJ, Hatherill M, TBVPX-203 study team.
doi: 10.1016/S2213-2600(20)30319-2
RECOMMENDED
Further Publications
Use of Pneumococcal and influenza vaccine in patients with COPD, asthma bronchiale and interstitial lung diseases in south east Germany
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Med
Mohr A, Plentz A, Sieroslawski A, Pezenburg F, Pfeifer M, Salzberger B, Hitzenbichler F
doi: 10.1016/j.rmed.2020.106207
RECOMMENDED
Asthma
Long-Term Azithromycin Reduces Haemophilus influenzae and Increases Antibiotic Resistance in Severe Asthma
Am J Respir Crit Care Med.
Taylor SL, Leong LEX, Mobegi FM, Choo JM, Wesselingh S, Yang IA, Upham JW, Reynolds PN, Hodge S, James AL, Jenkins C, Peters MJ, Baraket M, Marks GB, Gibson PG, Rogers GB, Simpson JL
doi: 10.1164/rccm.